Archived Webinar: Beyond Viral Hepatitis: Ascendance of Fatty Liver Disease in HIV
Beyond Viral Hepatitis: Ascendance of Fatty Liver Disease in HIV
Jennifer C. Price, MD, PhD
Release date: March 15, 2018
Expiration date: March 15, 2019
CME Credit Available: No longer available for CME Credit
Assessment of Needs
The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing liver complications in HIV-infected individuals as part of a nationwide continuing medical education (CME) effort for physicians.
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in the United States and is very common in HIV-infected individuals. This webinar will focus on the natural history of NAFLD and how clinicians can diagnose and evaluate HIV-infected patients at risk for NAFLD and adverse liver outcomes.
Upon completion of this webinar, learners will be able to:
- Recognize the clinical and histologic spectrum of nonalcoholic fatty liver disease (NAFLD)
- Identify which HIV+ patients are most likely to have NAFLD
- Describe the work-up for patients with suspected NAFLD
Who Should Attend
This advanced webinar is designed for clinical decision makers who are actively involved in HIV care and research.
This activity is also relevant for registered nurses, PharmDs, and other health professionals.
Please note: if you already have participated on the live webinar and have received CME credits, you will not receive additional credits from this activity.
Conflicts of Interest
In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.
Continuing Education Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors
Gilead Sciences, Inc
Frequently Asked Questions
View our list of FAQs about attending a webinar.
Please contact the registration department at registration“at”iasusa.org or 415-544-9400.
By clicking the link below, I acknowledge that I have read these instructions and understand them.
You must log in to take the activity.
How to Watch the Webinar
- Watch the webinar here.